Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Prostatectomy
Prostate Cancer Surgery Delay Not Linked to Worse Oncologic Outcomes
Deferring radical prostatectomy for intermediate- and high-risk prostate cancer for several months does not increase the risk for adverse oncologic findings.
Prostate Cancer Therapy Options Have Similar Cost-Effectiveness, Study Finds
Given that the findings do not show major differences between care options in prostate cancer, cost probably shouldn’t be a major factor driving decision making.
Routine Use of Neoadjuvant Docetaxel Plus ADT Not Supported in Localized, High-Risk Prostate Cancer
Patients with localized prostate cancer characterized by high-risk features are at increased risk of a negative outcome following radical prostatectomy.
Radium-223 Plus Sipuleucel-T Found to Slow mCRPC Progression
Combining sipuleucel-T and radium-223 improves progression-free survival among men with metastatic castration-resistant prostate cancer (mCRPC) who have bone predominant metastases, a randomized phase 2 study found.
Prostate Cancer Treatment Side Effects Worse With Prostatectomy
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
Statin Use Prior to PCa Surgery Has No Effect on Erectile Function Recovery
In a randomized, double-blind trial, short-term atorvastatin use before to radical prostatectomy did not improve postoperative erectile function compared with placebo.
Men With High-Risk PCa and Low PSA May Benefit More From Surgery Than Radiation
In a study, radical prostatectomy for men with Gleason 8-10 prostate cancer and low PSA levels was associated with a lower death risk compared with external beam radiation therapy with or without brachytherapy.
Routine mpMRI Use Leads to Earlier Treatment of Men on Prostate Cancer AS
Men on active surveillance for prostate cancer progress to treatment sooner if they undergo multiparametric MRI to identify clinically significant tumors.
Prostate Cancer Salvage Surgery, Ablation Offer Similar Outcomes
Radical prostatectomy and ablation for salvage treatment of radiorecurrent prostate cancer do not differ significant with regard to cancer-specific and metastasis-free survival, a study found.
-
Loading...
-
Loading...
Next post in Canadian Urological Association
